Clinical Trial Update: Study of Radiolabeled Revumenib in Adults With Acute Leukemia [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating radiolabeled revumenib in adults with acute leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Revumenib (radiolabeled) (revumenib)

Snippet

Sponsor: Syndax Pharmaceuticals | Conditions: Acute Leukemia | Phase 1 | Status: COMPLETED